国家医保局：对倒卖“回流药”等违法违规使用医保基金行为零容忍

Core Points - The National Medical Insurance Work Conference was held to summarize the work during the 14th Five-Year Plan and to outline plans for 2026 [1] - The conference emphasized the need to combat corruption in the medical field and to address issues related to improper practices affecting the public [1] - A total of approximately 120 billion yuan in medical insurance funds has been recovered over the past five years [1] - The implementation of drug traceability codes has led to the collection of over 100 billion codes, aiding in the crackdown on illegal activities such as the resale of "returned drugs" [1] Summary by Categories - Corruption and Improper Practices - The conference highlighted the ongoing efforts to address corruption and improper practices in the medical sector, with a focus on protecting public health rights [1] - Financial Recovery and Management - Approximately 120 billion yuan in medical insurance funds has been recovered through targeted management and oversight initiatives over the last five years [1] - Regulatory Measures and Future Plans - For 2026, there will be an increase in flying inspections to cover all regions and fund usage entities, particularly targeting areas with high out-of-pocket expenses for patients [1] - The conference reiterated a zero-tolerance policy towards illegal use of medical insurance funds, including the resale of "returned drugs," with strict penalties for violations [1]